Seed funding from St Vincent’s Research Clinic Foundation paved the way for a $4 million grant from Movember and the Australian Government. 

Each year in Australia, more than 24,000 men are diagnosed with prostate cancer, making it the most commonly diagnosed cancer in the country.

We acknowledge the groundbreaking advances in diagnosis and treatment for prostate cancer at St Vincent’s – and the incredible work of our people like grant recipient, Professor Louise Emmett, Director of Theranostics and Nuclear Medicine at St Vincent’s Sydney.

Professor Emmett’s work with PSMA-PET scans – a groundbreaking imaging test to detect prostate cancer – has been instrumental in developing more accurate methods of detection and treatment, picking up and targeting tumors where other types of scans may miss them.

St Vincent’s has conducted a multi-site clinical trial to assess the safety and efficacy of a new treatment protocol for men with metastatic prostate cancer. The results, published in The Lancet, showed that participants are living longer with significant improvements in pain and fewer adverse side effects.

Click the link to watch the full story on Nine News: Drug trial offers prostate cancer patients new hope (9news.com.au)

To help us continue to fund research taking place on the St Vincent’s Darlinghurst Health Innovation Precinct, please click here to donate now.